REBECCA DONOHUE: Open Payments
NPI 1124108501 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 20 payments from 12 companies in 2025. Trend: 2023 $492 · 2024 $746 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Incyte Corporation | 4 | $89 |
| SOBI, INC | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Aveo Pharmaceuticals, Inc. | 2 | $34 |
| Genentech USA, Inc. | 1 | $32 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: ELAHERE, JEMPERLI, MONJUVI, Doptelet, FOTIVDA, Itovebi, Vonjo, Tibsovo.
Industry payments across LA — which companies pay providers there.
